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Blood Pressure:  Systolic blood pressure (SBP) was 
measured daily in each mouse via the tail-cuff technique 
(Figure 8) using the CODA device from Kent scientific, 
(Torrington, CT).     
Surgery:  On day 5 (last day of Baseline period) surgery 
was performed on each mouse under isoflurane 
anesthesia to subcutaneously implant an Alzet
minipump (Figure 9) containing either vehicle or AngII
and a small pellet (either placebo or a pellet of 0.7 mg β-
estradiol).  The Vehicle-Placebo group contained the 
vehicle (i.e. saline) in the minipump and the implanted 
placebo pellet.  The AngII-Placebo group contained 
AngII, which resulted in an AngII infusion rate of 
1mg/kg/min, and the placebo pellet, and the AngII-E2 
group had the minipump with AngII and were implanted 
with the E2 pellet.   
Statistics: Data are shown as Mean ± SEM.  Repeated 
measures 2-way ANOVA was used to analyze SBP 
(GraphPad Prism7, Ca).  Fisher LSD was used for multiple 
comparisons. One-way ANOVA was used to measure 
average differences.  Differences of p < 0.05 were 
considered statistically significant.
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INTRODUCTION
Hypertension is a major risk factor for cardiovascular 
disease, chronic kidney disease, stroke, and other life-
threatening disorders.  Hypertension is where many 
physicians and health care providers begin when 
considering preventative health.  Treating hypertension to 
reduce its prevalence often involves the regulation of the 
renin-angiotensin-aldosterone system (RAAS), specifically 
the product Angiotensin II (AngII), using drugs to inhibit 
angiotensin converting enzyme (ACE inhibitors) and block 
the angiotensin II receptor (ARBS).  
Pre-menopausal women are known to have intrinsic 
protection against hypertension and cardiovascular 
disease compared to men of the same age. This 
protection is believed to be provided by estrogen.  Post-
menopausal women and age-matched men display a 
similar prevalence of hypertension-related diseases.  
• Determine if estrogen prevents or lessens AngII-
induced increase in blood pressure in ovariectomized 
(OVX) mice
• Determine if estrogen affects body weight, food intake, 
water intake, and urine production in mice. 
Animals:  OVX mice were obtained from Envigo
(Indianapolis, IN).  Ovariectomy was performed at 25 days 
of age.  Mice were 7 weeks old at the beginning of the 
study.  All experiments were approved by the OSU-CHS 
IACUC.  
Procedures:  The duration of the study was 16 days.  Mice 
were divided into three groups (n=4/group): Vehicle-
Placebo, AngII-Placebo, and AngII-Estrogen or AngII-E2.  
Mice were placed in metabolic cages (Figure 10) for a 
two-day acclimatization period followed by a 5-day 
baseline period.  Surgery was conducted on day 5 
followed by a recovery day, followed by a ten-day 
experimental (or AngII- period).  Daily measurements 
included body weight, food and water intake, urine 
volume, urine osmolarity, and urine Na+ and K+
concentrations.  A Wescor osmometer and EasyLyte
analyzer were used to measure urine osmolarity and 
electrolyte concentrations, respectively.  Mice consumed 
normal diet and water ad libitum.  
OBJECTIVES
METHODS  
1. Angiotensin II increased blood pressure in OVX mice.
2. Estrogen did not prevent AngII-induced increase in 
blood pressure.
3. Estrogen resulted in reduction in body weight.
4. Estrogen resulted in reduced food and water intake.  
5. Estrogen reduced sodium excretion and urine volume.  
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Figure 6: Sodium Excretion
Figure 5A: Daily SBP Figure 5B: SBP Baseline and Experimental
Figure 5: Systolic Blood Pressure (SBP)
Figure 5A shows daily SBP ± se of each group.  Surgery occurred on Day 5 and no measurement were 
taken. Figure 6B shows average SBP ± se in baseline period and AngII period.  * different from Vehicle 
Placebo (p<0.005) in AngII period.  No differences in baseline period. 
Figure 6A: Daily Sodium Excretion
Figure 4: Water Intake
Figure 4A: Daily Water Intake
Figure 4A shows daily water intake ± se of each group. Figure 4B shows average water intake ± se of each 
group in the AngII period.  * different from AngII Placebo (p<0.001).  No differences occurred in the 
baseline period.
Figure 6A shows daily sodium excretion ± se of each group. Figure 6B shows average sodium excretion  
± se of each group of each period in the AngII period.  * different from AngII Placebo (p<0.01).
Figure 7: Urine Volume
Figure 7A shows daily urine volume ± se of each group. Figure 7B shows average average urine volume  ±
se of each group of each period in the AngII period.  * different from Vehicle Placebo and AngII-E2 
(p<0.0001).
CONCLUSION
Estrogen did not protect the OVX female mice 
from the ten-day AngII-induced increase in blood 
pressure.  However, results suggest protection 
might occur in a longer time period.  
Estrogen appears to affect feeding and drinking 
behavior and renal sodium and water excretion.    
Figure 1: Basic characteristics of the
RAAS which plays a major role in
controlling blood pressure.
Koeppen, B. and Stanton, B: Renal
Physiology, 3rd ed. Mosby, 2001, p.99
Figure 2: Body Weight 
Figure 2A: Daily Body Weight Figure 2B: Δ Body Weight
Figure 2A shows daily mean ± se body weights of each group.  Surgery occurred on Day 5 and no 
measurement was taken on Day 6.  Figure 3B shows the delta body weight of each group (i.e. difference 
of each mouse at end of baseline period from that at end of AngII period.  * different from AngII-







Figure 7A: Daily Urine Volume 
Figure 7A: Urine Volume 
During Experimental Period
Figure 4B: Water Intake 
During Experimental Period
Figure 3: Food Intake
Figure 3A: Daily Food Intake
Figure 3A shows daily food intake ± se of each group. Figure 3B shows average food intake ± se of each 
group of each period in baseline period and AngII period.  * different from respective baseline value 
(p<0.001).
Figure 3B: Food Intake 
During Experimental Period
Figure 8: Kent Scientific CODA blood 
pressure tail cuff device.
Figure 9: Subcutaneous implantation of Alzet
pump which contained either Ang-II or saline. An 
estradiol or placebo pellet was also implanted 
subcutaneously next to the pump. 
Figure 10: Metabolic cage used to measure food and water intake, along with urine excretion.
Figure 8: SBP Method Figure 10: Metabolic CageFigure 9: Alzet Osmotic Pump
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